CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-17 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,900 | 137,610 | ||
| 2023-07-13 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +500 | $0.61 | $305 | 528,481 |
| 2023-07-13 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −500 | $16.13 | $8K | 527,981 |
| 2023-07-13 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −500 | 139,510 | ||
| 2023-07-12 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +201 | $0.61 | $123 | 528,182 |
| 2023-07-12 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −201 | $16.23 | $3K | 527,981 |
| 2023-07-11 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +500 | $0.61 | $305 | 528,481 |
| 2023-07-11 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −500 | $16.02 | $8K | 527,981 |
| 2023-07-11 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −500 | 140,211 | ||
| 2023-07-11 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −201 | 140,010 | ||
| 2023-07-10 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +1,202 | $0.61 | $733 | 529,183 |
| 2023-07-10 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,202 | $16.01 | $19K | 527,981 |
| 2023-07-10 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,202 | 140,711 | ||
| 2023-07-03 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +4,265 | $0.61 | $3K | 532,246 |
| 2023-07-03 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −3,865 | $16.30 | $63K | 528,381 |
| 2023-07-03 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −400 | $17.04 | $7K | 527,981 |
| 2023-07-03 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,265 | 141,913 | ||
| 2023-06-30 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +18,819 | $0.61 | $11K | 546,800 |
| 2023-06-30 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −18,819 | $16.97 | $319K | 527,981 |
| 2023-06-30 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,819 | 146,178 |
Page 10 of 21 · 417 trades